ThinkSabio

$NRXP

$3.05▲ +14.7% YTD

10 SEC 13D/G filings tracked · Last updated Oct 30, 2026

Filing History
News
NRXP ▲ +14.7% - NRx Pharmaceuticals, Inc.
CP $3.05▲ +14.7%Oct 30, 2026 · ThinkSabio Blog

$NRXP NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date…

News
NRXP ▲ +14.7% - NRx Pharmaceuticals, Inc.
CP $3.05▲ +14.7%Oct 30, 2026 · ThinkSabio Blog

$NRXP - NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date…

News
NRXP ▲ +0.4% - NRx Pharmaceuticals, Inc.
CP $2.71▲ +0.4%Oct 29, 2026 · ThinkSabio Blog

$NRXP - NRx Pharmaceuticals (Nasdaq: NRXP) to Host Conference Call on October 30, 2026 to Discuss Regulatory Milestone for Preservative-Free Ketamine…

News
NRXP ▲ +2.7% - NRx Pharmaceuticals, Inc.
CP $2.70▲ +2.7%Oct 20, 2026 · ThinkSabio Blog

$NRXP mentioned as possible play off earlier NYT article…

News
NRXP ▲ +7.3% - NRx Pharmaceuticals, Inc.
CP $2.79▲ +7.3%Oct 19, 2026 · ThinkSabio Blog

$NRXP - NRx Pharmaceuticals (Nasdaq:NRXP) Announces Completion of Manufacturing Process Validation and Two-Year Stability of Preservative-Free Ketamin…

News
NRXP ▼ -1.5% - NRx Pharmaceuticals, Inc.
CP $2.55▲ -1.5%Oct 15, 2026 · ThinkSabio Blog

$NRXP - NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine…

News
NRXP ▲ +2.4% - NRx Pharmaceuticals, Inc.
CP $2.99▲ +2.4%Sep 30, 2026 · ThinkSabio Blog

$NRXP - NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in…

News
NRXP ▼ -5.2% - NRx Pharmaceuticals, Inc.
CP $3.31▲ -5.2%Sep 15, 2026 · ThinkSabio Blog

$NRXP - NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ke…

News
NRXP ▼ -0.3% - NRx Pharmaceuticals, Inc.
CP $3.39▲ -0.3%Sep 14, 2026 · ThinkSabio Blog

$NRXP - GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral…

News
NRXP ▼ -1.2% - NRx Pharmaceuticals, Inc.
CP $3.36▲ -1.2%Sep 11, 2026 · ThinkSabio Blog

$NRXP - NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS Syst…